Axon Enterprise, Inc (NASDAQ:AXON) Given Average Rating of “Moderate Buy” by Brokerages

Axon Enterprise, Inc (NASDAQ:AXON) has received an average rating of “Moderate Buy” from the eighteen analysts that are currently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $841.6429.

A number of equities analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $870.00 target price on shares of Axon Enterprise in a research note on Wednesday, September 24th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. Bank of America boosted their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a report on Tuesday, August 5th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th.

Insider Buying and Selling

In other news, President Joshua Isner sold 15,919 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the sale, the president directly owned 238,379 shares of the company’s stock, valued at approximately $177,892,712.54. This represents a 6.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the completion of the sale, the chief financial officer directly owned 93,592 shares in the company, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 59,932 shares of company stock worth $45,115,616 in the last 90 days. 4.40% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. TCTC Holdings LLC grew its stake in Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after buying an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC grew its stake in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after buying an additional 33 shares during the last quarter. Banque Transatlantique SA acquired a new position in Axon Enterprise in the 1st quarter valued at about $31,000. Catalyst Capital Advisors LLC acquired a new position in Axon Enterprise in the 1st quarter valued at about $32,000. Finally, Flaharty Asset Management LLC acquired a new position in Axon Enterprise in the 1st quarter valued at about $33,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $727.41 on Thursday. The firm has a market cap of $57.10 billion, a PE ratio of 179.61, a PEG ratio of 27.75 and a beta of 1.41. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise has a 1-year low of $422.21 and a 1-year high of $885.91. The company has a fifty day moving average price of $756.79 and a 200 day moving average price of $710.65.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company’s revenue for the quarter was up 32.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts predict that Axon Enterprise will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.